Biofrontera AG (FRA:B8FK)

Biofrontera AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.46	3.12	3.08	6.38	6.91	16.55
Cash & Short-Term Investments	3.46	3.12	3.08	6.38	6.91	16.55
Cash Growth	56.28%	1.43%	-51.69%	-7.70%	-58.25%	48.81%
Accounts Receivable	2.16	6.47	7.16	2.07	1.21	3.5
Other Receivables	-	-	0.64	0.15	0.32	0.04
Receivables	2.16	6.47	7.8	2.22	1.52	3.54
Inventory	4.09	5.55	5.08	4.79	4.81	4.67
Prepaid Expenses	-	-	0.21	0.79	1.06	0.82
Other Current Assets	4.81	1.11	1.56	0.88	0.07	0.55
Total Current Assets	14.53	16.26	17.72	15.06	14.38	26.13
Property, Plant & Equipment	1.01	2.93	3.29	3.01	2.28	5.05
Long-Term Investments	0.34	0.42	1.72	8.98	53.15	-
Other Intangible Assets	-	1	1.15	1.2	1.14	17.69
Long-Term Accounts Receivable	-	0.01	0.03	0.1	-	-
Long-Term Deferred Tax Assets	3.94	9.03	6.82	4.38	5.75	7.53
Other Long-Term Assets	-0	0	0	0	0	-
Total Assets	19.81	29.65	30.73	32.73	76.7	56.39
Accounts Payable	1.33	2.12	2.59	1.98	2.74	1.62
Accrued Expenses	1.73	2.23	2.46	2.52	1.39	2.89
Current Portion of Long-Term Debt	-	-	-	-	2.09	0.08
Current Portion of Leases	0.52	0.44	0.47	0.45	0.36	1.06
Current Income Taxes Payable	0.08	0.38	0.84	0.16	-	-
Other Current Liabilities	1.34	5.3	3.71	3.28	10.89	2.63
Total Current Liabilities	4.99	10.47	10.07	8.39	17.47	8.29
Long-Term Debt	-	-	-	-	-	20.08
Long-Term Leases	0.02	0.33	0.68	1.06	0.85	2.66
Other Long-Term Liabilities	-	-	0	2.95	0.38	17.99
Total Liabilities	5.01	10.8	10.75	12.39	18.7	49.02
Common Stock	6.08	6.08	63.81	63.81	56.72	47.75
Retained Earnings	-128.8	-124.74	-181.16	-180.79	-136.05	-165.73
Comprehensive Income & Other	137.53	137.52	137.33	137.32	137.33	125.36
Shareholders' Equity	14.8	18.86	19.98	20.34	58	7.38
Total Liabilities & Equity	19.81	29.65	30.73	32.73	76.7	56.39
Total Debt	0.54	0.77	1.15	1.5	3.3	23.88
Net Cash (Debt)	2.92	2.36	1.93	4.88	3.61	-7.33
Net Cash Growth	127.19%	21.98%	-60.33%	35.12%	-	-
Net Cash Per Share	0.48	0.39	0.64	1.78	1.34	-2.84
Filing Date Shares Outstanding	6.08	6.08	3.04	3.04	2.7	2.7
Total Common Shares Outstanding	6.08	6.08	3.04	3.04	2.7	2.27
Working Capital	9.54	5.79	7.65	6.67	-3.09	17.84
Book Value Per Share	2.44	3.10	6.58	6.69	21.47	3.24
Tangible Book Value	14.8	17.86	18.83	19.14	56.86	-10.31
Tangible Book Value Per Share	2.44	2.94	6.20	6.30	21.05	-4.54
Machinery	-	4.67	4.46	3.68	3.55	3.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.